2-(3,4-Dichlorophenyl)-2-fluoroacetic acid, 95%, 500mg

Closing caps SILICOSEN®, C-40, Gesch. front, 27-40 mm 10 pcs

(R)-2-((tert-Butoxycarbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid, 95.0%, 1g

2-(3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)ethan-1-amine dihydrochloride, 95.0%, 1g

3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 97.0%, 5g

4-(1-aminoethyl)-1,6-heptadien-4-ol hydrochloride, 95.0%, 25g

5,7-Dichloro-1H-[1,6]naphthyridin-4-one, 95.0%, 250mg

Methyl 3-amino-4-(benzylamino)benzoate, 98%, 100mg

Boc-�-HoAsp(OBzl)-OH, 95%, 5g

2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid, 95.0%, 5g

1-Cycloheptyl-3-mesityl-1H-imidazol-3-ium chloride, 97%, 100mg

Hexadecyl 3,5-Di-tert-butyl-4-hydroxybenzoate>98.0%(GC)25g

3-[(4-methoxyphenyl)amino]-3-oxopropanoic acid, 95.0%, 1g